Company attributes
Other attributes
The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) is an American government organization which is a branch of the United States Army Medical Research and Materiel Command. It serves as a laboratory for the Department of Defense (DoD) and is the only lab that is able to safely study hazardous materials at the biosafety level of 4.
Since 1969, USAMRIID has served as the Department of Defense's (DoD) laboratory for medical biological defense research. Their research is conducted to protect soldiers from biological threats, investigate disease outbreaks, and threats to public health. Research conducted at USAMRIID leads to various solutions—therapeutics, vaccines, diagnostics, and information—that benefit military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.
The organization's stated mission is to provide medical drugs and therapies to protect and defend against current and emerging biological threats for both military and the public. It conducts research, development, and testing on vaccines for outbreaks such as Anthrax, Botulism, Plague, Ebola and Marburg hemorrhagic fevers, Hantavirus, Ricin toxin, and Staphylococcal enterotoxin B.
The USAMRIID has special access to the "animal rule" with the Food and Drug Administration (FDA). Following this rule, the organization's products can be considered for licensure by the FDA by testing its products on animals when human testing is not possible.
The organization has also worked in partnerships with other entities to develop Remdesivir, which has the potential to treat COVID-19. The USAMRIID laboratory has also received original samples of the virus so that it can be replicated and researched with the intention being able to conduct studies to create a vaccine and/or treatment for the virus.
